Definitive Healthcare (NASDAQ:DH) Receives Hold Rating from Needham & Company LLC

Definitive Healthcare (NASDAQ:DH)‘s stock had its “hold” rating reaffirmed by investment analysts at Needham & Company LLC in a report released on Wednesday, Benzinga reports.

DH has been the topic of a number of other research reports. Stifel Nicolaus reduced their target price on Definitive Healthcare from $11.00 to $9.50 and set a “buy” rating on the stock in a report on Wednesday, May 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating for the company in a research report on Thursday, May 9th. William Blair reaffirmed an “outperform” rating on shares of Definitive Healthcare in a research report on Tuesday, May 14th. Morgan Stanley downgraded Definitive Healthcare from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $11.50 to $9.00 in a research note on Wednesday, May 8th. Finally, Barclays cut their target price on Definitive Healthcare from $11.00 to $7.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 9th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $8.75.

Definitive Healthcare Stock Down 3.9 %

DH stock opened at $5.74 on Wednesday. Definitive Healthcare has a fifty-two week low of $4.38 and a fifty-two week high of $11.97. The business’s 50 day moving average price is $5.55 and its two-hundred day moving average price is $7.14. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.30 and a current ratio of 2.30. The company has a market capitalization of $676.92 million, a price-to-earnings ratio of -3.28, a price-to-earnings-growth ratio of 4.32 and a beta of 1.30.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Tuesday, May 7th. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). Definitive Healthcare had a positive return on equity of 0.51% and a negative net margin of 78.16%. The firm had revenue of $63.48 million for the quarter, compared to analysts’ expectations of $64.00 million. As a group, analysts forecast that Definitive Healthcare will post 0.1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Definitive Healthcare

Institutional investors have recently bought and sold shares of the stock. Arizona State Retirement System raised its holdings in Definitive Healthcare by 13.6% during the fourth quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock valued at $142,000 after acquiring an additional 1,701 shares during the period. Swiss National Bank increased its holdings in shares of Definitive Healthcare by 2.9% in the first quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after purchasing an additional 2,900 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Definitive Healthcare by 10.8% in the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock worth $218,000 after purchasing an additional 3,874 shares during the last quarter. OLD National Bancorp IN increased its holdings in shares of Definitive Healthcare by 19.6% in the fourth quarter. OLD National Bancorp IN now owns 24,652 shares of the company’s stock worth $245,000 after purchasing an additional 4,039 shares during the last quarter. Finally, SG Americas Securities LLC increased its holdings in shares of Definitive Healthcare by 30.0% in the fourth quarter. SG Americas Securities LLC now owns 18,802 shares of the company’s stock worth $187,000 after purchasing an additional 4,342 shares during the last quarter. 98.67% of the stock is owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.